本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Senti Biosciences, Inc.

0.3909
+0.01293.41%
盤後0.3774-0.0135-3.45%16:12 EDT
成交量:17.84萬
成交額:6.93萬
市值:1,217.44萬
市盈率:-0.23
高:0.4022
開:0.3800
低:0.3687
收:0.3780
52周最高:2.88
52周最低:0.3305
股本:3,114.45萬
流通股本:1,457.74萬
量比:0.46
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-1.7136
每股收益(LYR):-2.7326
淨資產收益率:-466.46%
總資產收益率:-65.57%
市淨率:-3.58
市盈率(LYR):-0.14

資料載入中...

2026/08/20

重要事件披露

Form 8-K - Current report
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/15

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/30

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/04/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/01

重要事件披露

Form 8-K - Current report
2026/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/19

重要事件披露

Form 8-K - Current report
2025/12/09

重要事件披露

Form 8-K - Current report
2025/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/13

重要事件披露

Form 8-K - Current report